Telehealth policy · deadline control
A telehealth deadline is safe to publish only when an editor has identified the controlling document, its effective period and any later action that amends or replaces it. A date copied from an older summary is not enough.
What the current federal record says
The Federal Register record available on the retrieval date identifies a fourth temporary DEA-HHS extension for prescribing controlled medications by telemedicine. Document 2025-24123 states that the rule is effective from January 1 through December 31, 2026. It also says the extension operates alongside other federal and state requirements.
That is a dated federal rule, not a permanent promise. A later final rule, correction, court action or another temporary measure could change the applicable pathway before this article’s proposed publication date. State law, professional licensure, the practitioner’s registration and the facts of a particular encounter remain separate questions.
A four-step deadline check
- Record the Federal Register document number, publication date and stated effective dates.
- Search the issuing agency page for later final rules, delays, corrections and extensions.
- Open the official PDF linked from the Federal Register record when legal precision matters.
- Stamp the article with the editor’s retrieval date and schedule a same-day recheck.
A federal prescribing flexibility does not by itself settle state licensure, consent, insurance coverage, pharmacy dispensing or whether a prescription is clinically appropriate.
What remains uncertain
The controlling rule on the eventual publication day cannot be frozen in this guide. Editors should not describe December 31, 2026 as a guaranteed endpoint or imply that an extension eliminates examination, documentation or legitimate-medical-purpose requirements.
What readers can verify next
Patients can ask a licensed clinician what evaluation is required for their situation and can confirm dispensing questions with a pharmacy. Clinicians and policy researchers should check the current Federal Register, DEA guidance and the law of the state where the patient is located. This newsroom does not determine eligibility or promise a prescription.